BIOSYNTIA ApS: Financial statements 2024
CVR: 34892970
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,051,793 and a net result of DKK -18,909,140 compared with DKK -29,430,438 the year before. Equity in the 2024 report amounted to DKK 52,926,908. The solvency ratio was 76.5%. The company had 12 employees in the financial year.
- Gross Profit
- DKK -14,051,793
- Profit/Loss
- DKK -18,909,140
- Equity
- DKK 52,926,908
- Total Assets
- DKK 69,170,284
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -14.1 mio. | -18.9 mio. | 52.9 mio. | 12 |
| 2023 | - | -17.8 mio. | -29.4 mio. | 71.8 mio. | 19 |
| 2022 | - | -16.6 mio. | -26.4 mio. | 101.3 mio. | 19 |
| 2021 | - | 1.2 mio. | -10.1 mio. | 16.2 mio. | 17 |
| 2020 | - | 818 t. | -9.4 mio. | 26.2 mio. | 21 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 31, 2024, Søren Knud Carlsen has left the board of directors of BIOSYNTIA ApS.
BIOSYNTIA ApS has published its annual report for 2023. Gross profit came to DKK -17,798,034, and the net result was DKK -29,430,438.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.